Board Meeting4 Nov 2026, 03:14 pm
3B BlackBio Dx Ltd Board Meeting on Nov 13, 2026 for Q2 Results
AI Summary
3B Blackbio Dx Ltd has announced that its Board of Directors will convene on November 13, 2026, to approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The trading window for designated persons and their immediate relatives will remain closed from October 1, 2026, until 48 hours after the results announcement.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results.
- Results pertain to the quarter and half-year ended September 30, 2026.
- Trading window closure announced for designated persons.
Price Impact
More from 3BBLACKBIO